FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emilia Wiechec

Research Profile

Disorders

Chemicals & Drugs

Devices

Drug Delivery Systems

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Emilia Wiechec; Eigil Kjeldsen; Jens Overgaard; Lise Lotte Hansen
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.
Emilia Wiechec
Implications of genomic instability in the diagnosis and treatment of breast cancer.
Emilia Wiechec; Carsten Wiuf; Jens Overgaard; Lise Lotte Hansen
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emilia Wiechec (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Emilia Wiechec; Eigil Kjeldsen; Jens Overgaard; Lise Lotte Hansen
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.
Cellular oncology (Dordrecht) 2013;36(2):113-20.
2011: Emilia Wiechec
Implications of genomic instability in the diagnosis and treatment of breast cancer.
Expert review of molecular diagnostics 2011;11(4):445-53.
2011: Emilia Wiechec; Carsten Wiuf; Jens Overgaard; Lise Lotte Hansen
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):397-407.
2010: S Lacoste; Emilia Wiechec; A G Dos Santos Silva; Amanda Guffei; G Williams; M Lowbeer; K Benedek; M Henriksson; G Klein; Sabine Mai
Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells.
Oncogene 2010;29(4):503-15.
2010: Kristina Pedersen; Emilia Wiechec; Bo E Madsen; Jens Overgaard; Lise Lotte Hansen
A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA).
BMC research notes 2010;3():179.
2009: Emilia Wiechec; Lise Lotte Hansen
The effect of genetic variability on drug response in conventional breast cancer treatment.
European journal of pharmacology 2009;625(1-3):122-30.
2009: Saeid Ghavami; Mohammad Hashemi; Sudharsana Rao Ande; Behzad Yeganeh; W Xiao; M Eshraghi; C J Bus; K Kadkhoda; Emilia Wiechec; Andrew J Halayko; Marek Los
Apoptosis and cancer: mutations within caspase genes.
Journal of medical genetics 2009;46(8):497-510.
2009: Subbareddy Maddika; Soumya Panigrahi; Emilia Wiechec; Sebastian Wesselborg; Ute Fischer; Klaus Schulze-Osthoff; Marek Los
Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of apoptin's anticancer toxicity.
Molecular and cellular biology 2009;29(5):1235-48.
2008: Thomas Klonisch; Emilia Wiechec; Sabine Hombach-Klonisch; Sudharsana R Ande; Sebastian Wesselborg; Klaus Schulze-Osthoff; Marek Los
Cancer stem cell markers in common cancers - therapeutic implications.
Trends in molecular medicine 2008;14(10):450-60.
2008: Emilia Wiechec; Jens Overgaard; Lise Lotte Hansen
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas.
Genes, chromosomes & cancer 2008;47(9):766-80.
2008: Subbareddy Maddika; Emilia Wiechec; Sudharsana Rao Ande; I K Poon; U Fischer; Sebastian Wesselborg; D A Jans; Klaus Schulze-Osthoff; Marek Los
Interaction with PI3-kinase contributes to the cytotoxic activity of apoptin.
Oncogene 2008;27(21):3060-5.
2008: Sabine Hombach-Klonisch; Ted Paranjothy; Emilia Wiechec; Paola Pocar; Tarek Mustafa; Anja Seifert; Christian Zahl; Klaus Luis Gerlach; Katharina Biermann; Klaus Steger; Cuong Hoang-Vu; Klaus Schulze-Osthoff; Marek Los
Cancer stem cells as targets for cancer therapy: selected cancers as examples.
Archivum immunologiae et therapiae experimentalis 2008;56(3):165-80.
2008: Subbareddy Maddika; Sudharsana Rao Ande; Emilia Wiechec; Lise Lotte Hansen; Sebastian Wesselborg; Marek Los
Akt-mediated phosphorylation of CDK2 regulates its dual role in cell cycle progression and apoptosis.
Journal of cell science 2008;121(Pt 7):979-88.
2007: Subbareddy Maddika; Graham H Bay; Tadeusz J Kroczak; Sudharsana Rao Ande; S Maddika; Emilia Wiechec; Spencer B Gibson; Marek Los
Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death.
Cell proliferation 2007;40(6):835-48.
2007: Subbareddy Maddika; Sudharsana Rao Ande; Soumya Panigrahi; Ted Paranjothy; Kazimierz Weglarczyk; Anne Zuse; Mehdi Eshraghi; Kamala D Manda; Emilia Wiechec; Marek Los
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2007;10(1-2):13-29.
2006: James B Johnston; Sri Navaratnam; Marshall W Pitz; Jerry M Maniate; Emilia Wiechec; Heinrich Baust; Joel Gingerich; GEORGIOS SKLIRIS; Leigh C Murphy; Marek Los
Targeting the EGFR pathway for cancer therapy.
Current medicinal chemistry 2006;13(29):3483-92.